Henry Brem, M.D.

Henry Brem, M.D.

DirectoratGalectin Therapeutics· In the 2025 proxy

Henry Brem, M.D. is Director of Galectin Therapeutics.

Experience

  1. Galectin TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role +321%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?